Inactivation of epoxide hydrolase by catalysis-induced formation of isoaspartate  by van Loo, Bert et al.
FEBS Letters 582 (2008) 1581–1586Inactivation of epoxide hydrolase by catalysis-induced formation
of isoaspartate
Bert van Loo, Hjalmar P. Permentier, Jaap Kingma, Helen Baldascini, Dick B. Janssen*
Biochemical Laboratory, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen,
Nijenborgh 4, 9747 AG Groningen, The Netherlands
Received 27 March 2008; accepted 3 April 2008
Available online 10 April 2008
Edited by Hans EklundAbstract Epoxide hydrolases catalyze hydrolytic epoxide ring-
opening, most often via formation of a covalent hydroxyalkyl-en-
zyme intermediate. A mutant of Agrobacterium radiobacter
epoxide hydrolase, in which the phenylalanine residue that ﬂanks
the invariant catalytic aspartate nucleophile is replaced by a
threonine, exhibited inactivation during conversion when the
(R)-enantiomer of para-nitrostyrene epoxide was used as sub-
strate. HPLC analysis of tryptic fragments of the epoxide
hydrolase, followed by MALDI-TOF and TOF/TOF analysis,
indicated that inactivation was due to conversion of the nucleo-
philic aspartate into isoaspartate, which represents a novel mech-
anism of catalysis-induced autoinactivation. Inactivation
occurred at a lower rate with the (S)-enantiomer of para-nitro-
styrene epoxide, indicating that it is related to the structure of
the covalent hydroxyalkyl-enzyme intermediate.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Epoxide hydrolases catalyze conversion of epoxides to diols
via a covalent hydroxyalkyl-enzyme intermediate [1–3]. This
reaction is of great importance in the mammalian metabolism
and detoxiﬁcation of xenobiotic compounds [4]. Epoxide
hydrolases can also be applied in industrial biocatalysis [5].
Most known epoxide hydrolases belong to the a/b-hydrolase
fold family, which implies that they have a catalytic triad com-
posed of a nucleophile, a histidine base, and an acidic amino
acid. In epoxide hydrolases, haloalkane dehalogenases, and
ﬂuoroacetate dehalogenases the nucleophile is an aspartate, in-
stead of the more common serine that is present in lipases and
other esterases of this protein family [6].
During our studies with some mutant epoxide hydrolases
that were found in a site-saturation library of Agrobacterium
radiobacter epoxide hydrolase (EchA) at position 108, we ob-
served that substrate conversion progress curves leveled oﬀ be-
fore complete conversion was achieved, and that the curves
could not be described by Michaelis–Menten kinetics with
product inhibition. This phenomenon indicated inactivation
of the enzyme during catalysis (van Loo et al., unpublished re-*Corresponding author. Fax: +31 50 3634165.
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doi:10.1016/j.febslet.2008.04.001sults). Previous results showed that EchA was irreversibly inac-
tivated during prolonged incubation with some diols that can
be produced from epoxides, most notably 1,2-octanediol [7].
This inactivation could be prevented by addition of a compet-
itive inhibitor, suggesting that inactivation was caused by
interaction of the 1,2-diol in the active site. Although inactiva-
tion was mostly irreversible, mass spectrometry measurements
indicated no net change in molecular mass during the inactiva-
tion process. Furthermore, circular dichroism (CD) measure-
ments showed that no unfolding of the enzyme occurred,
and only in the near-UV regions signiﬁcant changes were ob-
served, which were correlated to changes in the active site by
comparison of spectra of wild-type and mutant enzymes [7].
In this paper, we address the mechanism of inactivation of
an F108T mutant of EchA that is particularly sensitive to inac-
tivation upon incubation with its substrate (R)-para-nitrosty-
rene oxide. Residue F108 distally ﬂanks the nucleophilic
aspartate and is conserved as a bulky group in a/b-hydrolase
fold epoxide hydrolases. Kinetic measurements showed that
inactivation occurred on average once in every 119 catalytic
cycles and biochemical analysis of the inactivated enzyme sug-
gests that the active-site nucleophilic aspartate is converted
into isoaspartate.2. Materials and methods
2.1. Materials
We used mutant EchA F108T that was obtained from a site-satura-
tion library at position 108 (van Loo et al., manuscript in preparation).
Production and puriﬁcation of this mutant enzyme were done essen-
tially as described by Rink et al. [3]. (R)-para-nitrostyrene epoxide
((R)-pNSO) and (S)-pNSO were a gift of Enzis. The purity was
checked by HPLC (>98%). 1-(R)-para-nitrophenyl-1,2-ethanediol
was prepared by hydrolysis of a solution of (R)-pNSO with epoxide
hydrolase, followed by heat inactivation (10 min, 80 C) and removal
of protein by ﬁltration. The preparation contained 90% (R)-diol and
10% (S)-diol as judged by chiral HPLC [8]. Para-nitrophenyl glycidyle-
ther was obtained from Acros.
2.2. Enzymatic conversions
Conversion of epoxides and activity assays were carried out with puri-
ﬁed wild-type or F108T mutant epoxide hydrolase at 30 C in 50 mM
Tris Æ SO4 buﬀer, pH 7.5, and followed at 310 nm (pNSO) or 350 nm
(para-nitrophenyl glycidylether, pNPGE), as described previously [9].
In order to keep the absorbanceof substrate at the start of the conversion
below 1, the substrate concentrationwas lower than 250 lMin all exper-
iments. Amounts of diol formed and activities were calculated from the
decrease in absorbance (for pNSO, e310epoxide = 4289 M
1 cm1,
e310diol = 3304 M
1 cm1 and for pNPGE, e350epoxide = 4218 M
1 cm1,
e350diol = 4889 M
1 cm1). Enzyme reactivation was followed in the
same Tris buﬀer.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Kinetic resolution of rac-pNSO and concomitant enzyme
inactivation during turnover with F108T epoxide hydrolase (2.1 lM).
Symbols: r, (R)-pNSO; j, (S)-pNSO concentration.
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Circular dichroism (CD) spectra of EchA F108T before and after
incubation with (R)-pNSO were measured on an AVIV circular
dichroism spectrometer (62ADS). Far-UV spectra were recorded at
25 C from 190 to 250 nm in a 0.1 cm quartz cuvette using a bandwidth
of 1 nm. Spectra obtained from three scans were averaged and were
corrected for absorbance caused by the incubation solution. Near-
UV CD spectra of wild-type and mutant epoxide hydrolases were re-
corded from 250 to 310 nm using a 0.5 cm quartz cuvette. The spectra
of three scans, each recorded using a band width of 1 nm and steps of
1 nm, were averaged.
2.4. Tryptic cleavage of EchA F108T and HPLC analysis of digests
Puriﬁed EchA F108T, before and after incubation with (R)-pNSO,
was dialyzed against 100 mM NaHCO3, pH 8, and subsequently di-
gested with 1% (w/w) of trypsin for 18 h at 37 C. The digest was sub-
jected to HPLC, which was carried out on a Nucleosil C18 column
(5 lm, 250 · 2.1 mm) that was operated with a linear gradient of ace-
tonitrile (0–70% (v/v), 1 ml min1, 60 min) in 0.1% (v/v) triﬂuoroacetic
acid. Elution was followed at 214 nm and the target peptides were
manually collected, lyophilized and used for mass spectrometric anal-
ysis.
2.5. Mass spectrometry of EchA F108T peptides
The isolated peptides were dissolved in 50% acetonitrile containing
0.1% (v/v) triﬂuoroacetic acid and mixed with an equal volume of
10 mg ml1 a-cyano-4-hydroxycinnamic acid in the same solvent. Sam-
ples of 1.5 ll were spotted on the target and the samples were dried in
air. MALDI-TOF and TOF/TOF mass spectra were recorded using a
4700 Proteomics Analyzer (Applied Biosystems, Foster City, CA,
USA). Spectra were calibrated externally. Peptide fragmentation spec-
tra were produced with a collision energy of 1 keV and air as collision
gas at 1 · 106 Torr.3. Results
3.1. Inactivation behavior of EchA F108T
Kinetic resolution experiments with puriﬁed F108T mutant
epoxide hydrolase indicated that the enzyme became inacti-
vated during conversion of para-nitrostyrene oxide (pNSO),
although the protein was stable upon storage under the same
conditions in the absence of substrate. The F108T enzyme
exhibited enantioselectivity, but the conversion slowed down
over time and stopped after 91% of the preferred (R)-enantio-
mer and 49% of the (S)-enantiomer of pNSO were hydrolyzed0
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Fig. 2. Inactivation of F108T EchA by pNSO during substrate turnover. (A
enzyme for: (j), F108T EchA with 215 lM (S)-pNSO; (r), F108T EchA w
200 lM (R)-1-p-nitrophenyl-1,2-ethanediol. The slopes of the ﬁtted curves
molecule (transformation capacity). Horizontal dashed and dotted lines indi
and (R)-pNSO, respectively. (B) Recovery of activity during storage of F108(Fig. 1). When conversion stopped, the enzyme had performed
only 197 turnovers.
To monitor the inactivation in more detail, varying amounts
of F108T epoxide hydrolase were incubated with (R)-pNSO
(170 lM), and hydrolysis of epoxide to diol was followed at
310 nm in a spectrophotometer. The amount of epoxide that
was converted was proportional to the amount of enzyme
added, indicating that only a limited number of substrate mol-
ecules was turned over per enzyme molecule. When more than
1.5 lM enzyme was added, all of the (R)-pNSO (>95%) was
converted to its corresponding diol in 10 min (Fig. 2A). At en-
zyme concentrations below 1.5 lM, the amount of substrate
converted was incomplete and proportional to the amount of
enzyme added. The slope of the ﬁtted curve, which is 119, is
equal to the average number of conversions an enzyme mole-
cule performs before it is inactivated, which can be called the
transformation capacity.
The inactivation occurred faster with the preferred (R)-enan-
tiomer of pNSO than with (S)-pNSO, and the calculated trans-
formation capacity of F108T epoxide hydrolase with (S)-0
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ith 170 lM (R)-pNSO; (m), F108T EchA with 170 lM (R)-pNSO and
(r, 119; j, 404) represent the average maximal turnovers per enzyme
cate the level of diol formed in case of complete turnover of (S)-pNSO
T EchA (5 lM) at 4 C after removal of excess (R)-pNSO by dialysis.
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was incubated with (R)-pNSO in the presence of excess of
the product 1-((R)-p-nitrophenyl)-1,2-ethanediol (170 lM),
inactivation proceeded only somewhat faster than with (R)-
pNSO alone. Incubation of F108T EchA (5.4 lM) with
170 lM diol during 20 min at 30 C also did not lead to a de-
crease in enzyme activity (speciﬁc activity 10 ± 0.2 U/mg pro-
tein with pNPGE). Thus, the observed inactivation is not
due to a normal product inhibition. Instead, it must be caused
by substrate turnover. When wild-type enzyme (0.035 lM) was
incubated with 314 lM (R)-pNSO, >95% conversion occurred
in 20 min, in agreement with a kcat of 2.4 s
1 and a transforma-
tion capacity exceeding 10000, showing that wild-type EchA
was not sensitive to this substrate-turnover induced inactiva-
tion.
The inactivation process observed with the F108T mutant
was partially reversible. When protein that was inactivated
with (R)-pNSO was dialyzed to remove remaining substrate
and stored at 4 C, up to 30% of the activity was regained in
12 days, after which no further activity increase was observed
(Fig. 2B).
Biochemical characterization of the F108T mutant EchA be-
fore and after inactivation by (R)-pNSO by far-UV circular
dichroism (CD) (Fig. 3A) indicated that unfolding events were
not the cause of the inactivation since a-helix and b-sheet con-
tent did not change. Near-UV CD spectra, however, indicatedFig. 3. Circular dichroism (CD) spectra for EchA F108T before (black line) a
in showing that no major structural changes were the cause of the inactivation
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Fig. 4. HPLC elution pattern of tryptic digests of native EchA F108T (A) and
inactivated enzyme at 30.69 min (b1) is missing in the native enzyme (a1). Th
in the insets (a2, b2), were analyzed by MALDI-TOF MS.that the direct environment of aromatic residues in and near
the active site had changed signiﬁcantly (Fig. 3B). Initial anal-
ysis of peptide samples obtained by tryptic cleavage showed no
gross changes in the digestion pattern, and no indication for
cross linking was obtained. These observations indicated that
a subtle covalent modiﬁcation, which did not result in a large
change of the molecular weight or a major unfolding event,
was responsible for the observed conversion-induced inactiva-
tion process.
3.2. Mass spectrometric analysis
To further analyze the biochemical cause of the inactivation,
samples of native F108T EchA and of protein that was incu-
bated with (R)-pNSO were digested with trypsin and analyzed
by reverse phase HPLC (Fig. 4). The only clear diﬀerence that
could be observed was the elution of an additional small peak
for the peptide digest of the inactivated enzyme (b1, elution
time 30.7 min). The diﬀerences in the peaks around 45 min
were caused by slight retention time variations or incomplete
digestion, and no peptides of interest were observed in them.
The 30.7 min peak which preceded a large peak that was pres-
ent in both spectra (a2 and b2), was absent in the native en-
zyme (Fig. 4). Mass spectrometric analysis by MALDI-TOF
of this peptide (b1) indicated that it had a protonated mass
of 1593.9 Da. The same mass was found in the larger peaks
b2 and a2, which eluted just after peak b1, as well as for thend after (gray line) incubation with (R)-pNSO. (A) Far UV CD spectra
. (B) Near-UV spectra pointing to a small local change in environment.
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of EchA F108T exposed to (R)-pNSO (B). The peak that appears with
is peptide and the next eluting peptide, represented by the largest peaks
1584 B. van Loo et al. / FEBS Letters 582 (2008) 1581–1586material collected as a small shoulder (a1) at the same reten-
tion time as b1, which presumably contains 1593.9 material
from the a2 peak. The major component of peaks b2 and a2
was a diﬀerent peptide with a protonated mass of 1227.6 Da.
The 1593.9 Da peak corresponds to the tryptic peptide
AYVVGHDTAAIVLHK, which harbors the active-site nucle-
ophile, aspartate 107. Thus, the retention time of this peptide
as it is present in peak b1 has changed as compared to the ori-
ginal peptide (at positions a2 and b2), but without a change in
net mass.
One possible covalent modiﬁcation that we considered is
rearrangement of Asp107 to form isoaspartate. Isoaspartate
linkages are known to be formed in some proteins via succin-
imide-linked deamidation of asparagines and rearrangement of
aspartic acids [10]. Such a modiﬁcation can be detected by tan-
dem mass spectrometry [11–13]. The MALDI-TOF/TOF frag-
mentation spectra of the peptide corresponding to peak b1
indeed showed a pattern that clearly diﬀered from that of the
other three peptides (Fig. 5A).
The spectrum from the inactivated peptide (b1) showed a
clear decrease in intensity of the b8, b9 and b10-ions and an in-
crease in intensity of the y8 and y9-ions (Fig. 5B), as compared
to the control peptides (a1, a2, b2). The respective b- and y-ion
masses of all four peptides are the same, but the distinct diﬀer-
ence in intensities strongly suggests that peptide b1, from the
modiﬁed and inactivated protein, is structurally diﬀerent from
the control peptides. Most signiﬁcantly, the peptide yielded an
additional, unique fragment that is generated by loss of
HCOOH from the y9 ion (Dm = 46 Da, peak d in Fig. 5B),
which has isoaspartate as the N-terminal residue. During
molecular fragmentation, loss of the a-carboxylic acid moiety
of isoaspartic acid is more favorable than loss of the b-carbox-
ylic acid group from aspartic acid [12,13]. Gogichaeva et al.
[14] have found that this is a general diﬀerence in fragmenta-
tion of a- and b-amino acids by MALDI-TOF/TOF. The
observation of the isoaspartate-speciﬁc fragment clearly showsR
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Fig. 5. MALDI-TOF/TOF fragmentation spectra of the 1593.9 Da peptides
(A) Peptides from active enzyme (HPLC peaks a1 and a2) and enzyme ina
detected from peak b1 show a decreased intensity of the b-ions, and an inc
isoaspartate speciﬁc fragment (d) formed by decarboxylation (y9-46 Da) isthe generation of isoaspartate and indicates that this is the
mechanism of the observed enzyme inactivation.
The putative succinimide intermediate, with a protonated
mass of 1575.9 Da, was not observed by MALDI-TOF. Since
the analysis was performed under acidic conditions, the succin-
imide is expected to be hydrolyzed to aspartate/isoaspartate.
The control peptides do not show any isoaspartate (as judged
from the absence of the y9-46 fragment peak). It is possible
that (some of) the inactivated protein contained the succini-
mide intermediate which would subsequently be hydrolyzed
during sample preparation. Since both aspartate and isoaspar-
tate can be formed by hydrolysis, this would underestimate the
amount of modiﬁed peptide and protein.4. Discussion
A peculiar observation with EchA F108T was that it quickly
underwent inactivation during turnover of para-nitrostyrene
epoxide. This phenomenon was only observed when the (R)-
enantiomer was converted and could be described as a parti-
tioning process in which enzyme either became inactivated or
converted substrate catalytically. The average number of cata-
lytic cycles leading to inactivation was 119. The inactivation
was also not observed with wild-type enzyme and was inﬂu-
enced by the stereoconﬁguration of the substrate. The (S)-
enantiomer was converted more slowly and a much lower rate
of inactivation was found.
HPLC and mass spectrometry only suggested a single
change in the peptide proﬁle of the inactivated protein: the
nucleophilic aspartate in the native enzyme was converted into
an isoaspartate in the (R)-pNSO-exposed enzyme. This was
clearly indicated by the loss of a carboxylic acid group in the
peptide that originated from inactivated EchA F108T, as well
as by the reduction in intensity of b fragments and the increase
in intensity of y fragments in the MS/MS fragmentation spec-800 850 900 950 1000 1050 1100 1150
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isolated by HPLC. The peptide sequence is AYVVGHDTAAIVLHK.
ctivated with (R)-pNSO (HPLC peaks b1 and b2). (B) The fragments
reased intensity of the y-ions, indicated with arrows. Furthermore, an
observed only in peak b1.
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contain isoaspartic acid [11–13].
We propose that the inactivation is caused by a rearrange-
ment of the covalent alkyl-enzyme intermediate that is formed
during the ﬁrst half reaction of the catalytic cycle, which is
epoxide ring-opening. Dependent on the nature of the sub-
strate, the hydroxyalkyl-intermediate of the F108T mutant en-
zyme would occasionally be cleaved by intramolecular
nucleophilic attack by the backbone amide nitrogen of the
amino acid distal to the active-site aspartate. This reaction is
similar to the one that spontaneously occurs in some proteins
in which isoaspartate linkages are formed between Asp/Asn
and their distal residues via a succinimide intermediate [10].
Hydrolysis of the intermediate would lead either to reactivated
enzyme, or to formation of isoaspartic acid (Fig. 6). The fact
that this phenomenon is observed in a mutant enzyme and
hardly in the wild-type enzyme, which respectively have a thre-
onine and phenylalanine ﬂanking the nucleophilic aspartate, is
in agreement with the eﬀect that side chains of residues distally
ﬂanking Asn or Asp residues can have on the acidity of the
backbone amide that is involved in the formation of the suc-
cinimide intermediate [15]. The nitrogen that performs the
nucleophilic attack that results in the formation of the interme-
diate is more easily deprotonated and therefore more nucleo-
philic at alkaline to neutral pH if a residue such as serine or
threonine is present instead of a more apolar residue such as
phenyl alanine [15]. The nature of the reactivation process,
which is only partial and proceeds slowly, may be cleavage
of the succinimide intermediate to active enzyme, although this
has not been proven.
Formation of succinimide intermediates and isoaspartic
groups in proteins have been observed in many cases [16–18]
most notably during aging of a protein, but has, to our knowl-
edge, not been associated with a catalytic event in an enzyme
active-site. The results described here thus identify a novelN
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Fig. 6. Mechanism of inactivation of F108T epoxide hydrolase upon
incubation with (R)-pNSO. We propose that (R)-pNSO can act as a
substrate when the covalent intermediate is cleaved in the normal way
(route 1). However, instead of water, the backbone amide nitrogen of
the residue distal to the aspartate may perform a nucleophilic attack on
the carbonyl carbon of the alkyl-enzyme intermediate. This produces a
succinimide intermediate, that may undergo hydrolysis to reform
native enzyme (route 2a, reactivation) or it may be cleaved at the main
chain carbonyl function, which produces an isoaspartate residue in the
main chain at position D107 (route 2b).mechanism by which an enzyme that possesses a nucleophilic
aspartate may become inactivated. If this mechanism also is
of importance for other enzymes that rely on formation of
covalent intermediates involving an aspartate remains to be
established. We have observed that the slow inactivation that
is observed when wild-type EchA is exposed to some 1,2-diols
(products) is accompanied by alterations in the CD spectrum
and irreversible loss of activity without unfolding or changes
in molecular mass [7], which suggests that high concentration
of product may evoke similar inactivating modiﬁcations in
the active site of an epoxide hydrolase, possibly by formation
of a covalent or non-covalent enzyme-product complex.
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